AlphaYouIG
Schedule 13G filing
ING GROEP NV cut its Tenax Therapeutics, Inc. (TENX) stake below 5%
ING GROEP NV reported owning 0% of Tenax Therapeutics, Inc. (TENX) in a Schedule 13G filed Sep 11, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Sep 11, 2026
- Source
- Schedule 13G
More TENX insider and Congress trades
- BuyTENX · Declan Doogan$102KSep 18, 2026
- BuyTENX · Christopher Thomas Giordano$20KSep 16, 2026
- BuyTENX · Thomas R Staab II$11KSep 16, 2026
- BuyTENX · Adar1 Capital Management, Llc$1.6MSep 8, 2026
- BuyTENX · Adar1 Capital Management, Llc$1.4MSep 2, 2026
- BuyTENX · Adar1 Capital Management, Llc$1.8MAug 24, 2026
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.